Results 221 to 230 of about 3,231,328 (345)
Effects of eculizumab and rituximab on visual function, motor function and social quality in patients with NMOSD: a comparative study. [PDF]
Liu Y +6 more
europepmc +1 more source
ABSTRACT Objective People with epilepsy (PWE) may experience cognitive deficits but fail to undergo formal evaluation. This study compares cognitive status between PWE and healthy controls in the West African Republic of Guinea. Methods A cross‐sectional, case–control study was conducted in sequential recruitment phases (July 2024–July 2025) at Ignace ...
Maya L. Mastick +14 more
wiley +1 more source
Case of autosomal dominant optic atrophy with relatively good visual function. [PDF]
Tachibana M +6 more
europepmc +1 more source
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin +11 more
wiley +1 more source
Exploring the impact of visual function degradation on manual prehension movements in normal-sighted individuals. [PDF]
Sanz Diez P +5 more
europepmc +1 more source
An Out‐of‐Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic
ABSTRACT The FMR1 gene premutation (55–200 CGG repeats) is usually associated with a wide range of symptoms and phenotypes within the Fragile X‐tremor/ataxia syndrome (FXTAS), but may also manifest as predominant or isolated cognitive decline. We describe three male patients referred for progressive cognitive impairment and behavioral changes. Standard
Guido Greco +7 more
wiley +1 more source
Eye tracking for the classification of visual function in individuals with vision impairment: A validation in Para athletes. [PDF]
Nieboer W, Mann DL.
europepmc +1 more source

